XML 24 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes
12 Months Ended
Aug. 27, 2017
Income Tax Disclosure [Abstract]  
Income Taxes

6. INCOME TAXES

 

  Income taxes consisted of the following:

 

    Years Ended  
    August 27, 2017     August 28, 2016     August 30, 2015  
                   
Current:                        
Federal   $ (12,055 )   $ (187,241 )   $ 102,448  
State     9,690       9,500       10,821  
      (2,365 )     (177,741 )     113,269  
Deferred:                        
Federal     (478,531 )     (200,433 )     (44,441 )
State     (9,136 )     (169,122 )     (54,112 )
      (487,667 )     (369,555 )     (98,553 )
Total   $ (490,032 )   $ (547,296 )   $ 14,716  

 

  A reconciliation of the federal income tax provision at the statutory rate with actual taxes provided on earnings from continuing operations is as follows:

 

    Years Ended  
    August 27, 2017     August 28, 2016     August 30, 2015  
Ordinary federal income tax statutory rate     (34.0 )%     (34.0 )%     34.0 %
Income tax credits     (4.4 )     (107.1 )     (27.0 )
Domestic production activities deduction     (.2 )     (6.1 )     (6.5 )
State income taxes net of federal tax effect     1.0       1.0       1.0  
Effective rate     (37.6 %)     (146.2 )%     1.5 %

 

  Deferred income taxes are provided for the temporary differences between the financial reporting and tax basis of the Company’s assets and liabilities. Temporary differences comprising the net deferred taxes on the balance sheet are as follows:

 

    August 27, 2017     August 28, 2016  
Deferred Tax Assets                
Accrued liabilities   $ 127,765     $ 61,977  
Inventory     71,013       122,871  
Tax credit carryforwards     710,198       717,856  
Stock option expense     363,632       323,728  
Other     16,456       7,346  
      1,289,064       1,233,778  
Less: valuation allowance     (27,473 )     (21,212 )
Net deferred tax assets     1,261,591 )     1,212,566 )
                 
Deferred Tax Liabilities                
Tax depreciation and amortization greater than book     (2,176,659 )     (2,615,301 )
                 
Net deferred taxes   $ (915,068 )   $ (1,402,735 )

 

The Company’s effective tax rate in its year ended August 27, 2017 was a negative (37.6%) as compared to a negative (146.2%) for the year ended August 28, 2016 and 1.5% for the year ended August 30, 2015, respectively. During fiscal 2016, the Company hired an outside consulting firm to conduct an analysis to determine if certain activities the Company performs qualifies for the Research & Development tax credit (R&D credit) as defined by Internal Revenue Code Section 41. As a result of the analysis, the Company determined that it is performing activities that qualify for the R&D credit, and during the fiscal year 2016 recognized tax benefits related to R&D tax credits from several prior years which lowered the overall effective tax rate. In addition, during the Company’s fiscal 2016 second quarter, the Federal R&D tax credit law was retroactively renewed for calendar year 2015 and also made permanent going forward. Since for calendar year 2015 the law was enacted retroactively, any effects are recognized as a component of income tax expense or benefit from continuing operations in the financial statements in the interim period that the law was enacted, which in this case was the Company’s fiscal 2016 second quarter. The Company believes that it has recognized R&D tax benefits for all prior years to the extent possible.

 

As of August 27, 2017, the Company has federal alternative minimum tax credit carryforwards of approximately $347,000 and approximately $209,000 in federal R&D tax credit carryforwards. The Company also has $254,000 in state R&D tax credit carryforwards and $23,000 in state alternative minimum tax credit carry forwards. The R&D tax credit carryforwards that are related to state jurisdictions begin to expire starting in 2018. The federal R&D tax credits begin to expire in 2033 while the alternative minimum tax credit carry forwards do not expire.

 

The Company files income tax returns in the U.S. federal and various state jurisdictions. The Company classifies interest and penalties arising from unrecognized income tax positions in income tax expense if they occur. At August 27, 2017 and August 28, 2016, the Company had no accrued interest or penalties related to uncertain tax positions.

 

As previously discussed, the Company has R&D tax credits related to state jurisdictions. These credits can be carried forward for fifteen years before they expire. The Company applies the accounting standard for recognition of deferred tax assets pursuant to a more-likely-than-not threshold. The Company believes that it is more likely than not that some of its’ state R&D tax credits will expire before they can be utilized. Due to this, the Company established a valuation allowance of $27,473 at August 27, 2017. The Company also applies the more-likely-than-not accounting standard for uncertain tax positions to determine the recognition and derecognition of uncertain tax positions. Once the more-likely-than-not threshold is met, the amount of benefit to be recognized is the largest amount of tax benefit that is greater than 50 percent likely of being ultimately realized upon settlement. It further requires that a change in judgment related to the expected ultimate resolution of uncertain tax positions be recognized in earnings in the period of such a change. Below is a summary of uncertain tax positions:

 

Uncertain tax positions at August 31, 2014   $ -  
Increase for tax positions related to prior years     30,000  
Uncertain tax positions at August 30, 2015     30,000  
Increase for tax positions related to prior years     3,778  
Uncertain tax positions at August 28, 2016     33,778  
Increases for tax positions related to prior years     182  
Uncertain tax positions at August 27, 2017   $ 33,960  

 

The Company does not believe there will be significant changes to the estimates in the next 12-month period. Due to the complexity of some of these uncertainties, the ultimate settlement may result in payments that are different from our current estimate of tax liabilities, resulting in the recognition of additional charges or benefits to income tax expense.

 

The Company incurred the following research and development expenses for the following years ended:

 

August 27, 2017   $ 999,000  
August 28, 2016   $ 994,000  
August 30, 2015   $ 942,000  

 

The research and development expenses consist primarily of engineering costs associated with the startup of new parts and programs and the development and testing of improvements on existing parts and programs. With each new part or program that the Company secures, the Company has to develop the methods to manufacture these parts. Once the methods have been established, they need to be tested and proven on the manufacturing floor. In many cases, these tests result in the methods being refined or overhauled based on the experiences from the manufacturing floor.